New daily shot could free hypoparathyroidism patients from pills
NCT ID NCT05387070
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a daily injection called TransCon PTH in 81 adults with hypoparathyroidism, a condition where the body lacks parathyroid hormone, causing low calcium levels. The goal was to see if the drug could bring calcium levels back to normal and allow patients to stop taking high doses of vitamin D and calcium supplements. Participants were randomly assigned to receive either the drug or a placebo for 26 weeks, followed by a long-term extension where everyone received the drug.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOCRINE SYSTEM DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Testosterone may rebuild strength after spinal cord injury — trial puts it to the test
- Childhood brain tumor survivors face hidden hormone risks years later
- Could a daily shot free teens from calcium pills?
- Could a metabolic modulator help people with type 1 diabetes use insulin better?
- Weekly shot could free hypoparathyroidism patients from daily pills
- Weekly shot could replace daily needles for kids with growth hormone deficiency